BPC-157 Beligas 5 mg
The Beligas BPC-157 listing whose recorded image identifies BPC 157 and 5 mg.
View label and detailsBrowse eight Beligas listings with detailed information. Compare substance names, presentation names and package formats, then open each listing for label details.
The Beligas BPC-157 listing whose recorded image identifies BPC 157 and 5 mg.
View label and detailsThe Beligas TB-500 listing shows 5 mg in the existing image; it is a separate listing from BPC-157.
View label and detailsThe Beligas HCG listing with 5000 IU shown on the box-and-vial image.
View label and detailsBeltropin by Beligas in the box-and-vial presentation, distinct from the pen listing.
View label and detailsBeltropin Pen by Beligas, with 36 IU shown on the pen-and-box image.
View label and detailsThe Beligas IGF-1 LR3 listing shows 1 mg in the box-and-vial image.
View label and detailsBelzempic is the semaglutide pen name used in the Beligas listing.
View label and detailsBeljaro EZUSE is the tirzepatide pen name used in the Beligas listing.
View label and detailsBeltropin 100 IU is the carton-and-vial listing; Beltropin Pen 36 IU is the pen listing. These figures identify the listings and are not usage instructions.
No. Belzempic is the semaglutide listing, while Beljaro EZUSE is the tirzepatide listing. Read their substance and label information separately.
General listing or label enquiries: LINE @musclestationth
Listing links checked: 12 September 2026. Detailed evidence is linked from each product page.